Beta-Blocker Heart Attack Trial (BHAT)

NCT00000492 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Arrhythmia
Cardiovascular Diseases
Coronary Disease
Death, Sudden, Cardiac
Heart Diseases
Myocardial Infarction
Myocardial Ischemia
Ventricular Fibrillation

Interventions

DRUG: propranolol

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)